Apple, Nvidia and Pfizer fall premarket; Lululemon rises
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/28/2026
- Wall Street ends mixed as investors focus on tech earnings
- NVIDIA’s rising CDS the talk of Wall Street amid circular financing fears
- Market watchers weigh chances of a surprise Fed rate hike tomorrow
- U.S. chip stocks extend losses on AI financing, China competition fears
- Tesla to buy power from Arizona solar project
- Visa (V) To Cut 7% Of Its Workforce, Totaling About 2,600 Jobs - Bloomberg
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- Applied Digital (APLD) Tops Q4 EPS by 23c, Revenue Beats
Apple (AAPL) iPhone 15 demand 'declines across all regions' - UBS
October 18, 2023 9:03 AM EDTThe demand for the Apple (NASDAQ: AAPL) iPhone 15 Pro has declined across all regions relative to last year, according to a note from UBS analyst David Vogt on Wednesday.
The analyst, who has a Neutral rating and $190 per share price target on Apple shares,... More
Here's why Wells Fargo sees this homebuilder stock as a top pick
October 17, 2023 2:16 PM EDTIn a market where concerns about the housing market are rife, it is somewhat of a surprise to see Wells Fargo name one home construction firm as a top pick.
Analysts at the investment bank made the case for housing in a note this week, stating that while they understand homebuilding is cyclical and rates "are a... More
Apple (AAPL) iPhone 15 availability improving - BofA
October 17, 2023 8:59 AM EDTBofA analyst Wamsi Mohan said that the Apple (NASDAQ: AAPL) iPhone 15 and 15 Pro availability picked back up over the last week.
Mohan, who has a Neutral rating and $208 price target on the stock, said availability for the models is improving, with the firm's proprietary interactive dashboard... More
Moderna (MRNA) 'remains comfortable' with Covid vaccine guidance range after Pfizer slashes forecast
October 16, 2023 2:29 PM EDTPharmaceutical company Moderna (NASDAQ: MRNA) released a short statement Monday, aiming to ease worries regarding sales of its Coivd vaccine.
The company's share price dropped Monday after larger rival Pfizer (NYSE: PFE) slashed its 2023 revenue projection by $9 billion late Friday.... More
Deutsche Bank Reacts to Charles Schwab Corp. (SCHW) Q3 2023 Earnings Report
October 16, 2023 9:52 AM EDTDeutsche Bank analyst Brian Bedell reiterated a Buy rating and $69.00 price target on Charles Schwab Corp. (NYSE: SCHW).
The analyst comments "We view SCHW's 3Q EPS as being overall better than expected with cash sorting easing in September vs. August to monthly... More
Apple (AAPL) Demand in Europe/India Said to be 'Strong" at OTR Global, Demand Stable or Recovered in China/US
October 16, 2023 9:49 AM EDTApple (NASDAQ: AAPL) Demand Said to be 'Strong" at OTR Global
Apple's 3Q23 iPhone sell-through in Europe and India was boosted by strong iPhone 15 demand, while yy sell-through trends in China and at U.S. retail stores slightly recovered or remained stable.... More
Wolfe Research Reacts to Charles Schwab Corp. (SCHW) Q3 2023 Earnings Report
October 16, 2023 9:33 AM EDTWolfe Research analyst Steven Chubak reiterated an Outperform rating and $75.00 price target on Charles Schwab Corp. (NYSE: SCHW).
The analyst comments "Key Highlights: NII, Deposits / Deposit Costs, FHLB Balances, Sweep Cash, BDA Fees, AOCI / TCE, Capital. NII of $2.37B was... More
Citi Reacts to Charles Schwab Corp. (SCHW) Q3 2023 Earnings Report
October 16, 2023 9:32 AM EDTCiti analyst Chris Allen reiterated a Buy rating and $75.00 price target on Charles Schwab Corp. (NYSE: SCHW).
The analyst comments "SCHW reported 3Q23 EPS of $0.77 (vs our est./consensus of $0.75/0.74). Relative to our estimates, the beat was driven by higher revenue (better... More
Moderna (MRNA) remains comfortable with its guided range for FY23 Covid vaccine sales
October 16, 2023 9:03 AM EDT(Updated - October 16, 2023 9:04 AM EDT)
Moderna (NASDAQ: MRNA) disclosed:
On October 16, 2023, Moderna, Inc. (the Company) provided the following statement on the Statements and Perspectives webpage of its Investor Relations... More
Morgan Stanley cuts Apple (AAPL) price target but doesn't see earnings as a material stock catalyst
October 16, 2023 8:56 AM EDTApple's (NASDAQ: AAPL) price target was cut to $210 from $215 at Morgan Stanley on Monday as the firm believes the company's F4Q23 is unlikely to settle any bull/bear debates.
Analyst Erik Woodring, who maintained an Overweight rating on the stock, told investors in a note that they expect an in-line September... More

